CMO

Showing 15 posts of 30 posts found.

Boehringer image

Boehringer says it is rolling out ‘fully disposable’ biomanufacturing

September 18, 2012
Manufacturing and Production Boehringer, CMO, GMP, SUSs

Boehringer Ingelheim says it has developed a production platform for biopharmaceuticals that makes full use disposable technologies both upstream and …

Boehringer wins contract to make Servier’s gevokizumab

August 7, 2012
Manufacturing and Production Boehringer Ingelheim, CMO, Servier, antibody

Boehringer Ingelheim’s contract manufacturing organisation (CMO) division will provide commercial-scale manufacturing of a new monoclonal antibody developed by Servier and …

Scinopharm Taiwan to build injectable drug facility

July 3, 2012
Manufacturing and Production CMO, HPAPI, R&D, Scinopharm Taiwan

Contract manufacturing organisation Scinopharm Taiwan has said it plans to invest around $37.6 million in a new high-potency active pharmaceutical …

Europe’s CMO market set to double by 2018, says F&S

May 30, 2012
Manufacturing and Production CMO, Europe, F&S, R&D, Taylor, manufacturing

The European market for pharmaceutical contract manufacturing will double from a value of around $10 billion last year to almost …

brian_jolly_at_onyx_scientific_

Onyx appoints Brian Jolly to commercial team

May 30, 2012
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing CMO, Onyx, manufacturing

Onyx Scientific the chemistry and manufacturing specialist has bolstered its business development team with the appointment of a new director. …

AMRI announces president for AMRI Europe

May 23, 2012
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing AMRI, AMRI Europe, CMO

Contract research and manufacturing organisation AMRI has announced the appointment of Ian Shott as president of AMRI Europe.  In this …

Outsourcing on the up, but contract manufacturing still under pressure

May 11, 2012
Manufacturing and Production CMO, Jim Millar, PharmaSource, Phil Taylor, outsourcing

The pharmaceutical contract services sector experienced something for a recovery in 2011 after a lean couple of years, although the …

Patheon starts winding down Swindon operations

May 10, 2012
Manufacturing and Production CMO, Patheon, Swindon, manufacturing

North American contract manufacturer Patheon is winding down some operations at its facility in Swindon, UK, with the aim of …

Teva image

Teva sells Canadian plant to CMO

March 30, 2012
Manufacturing and Production CMO, Halo Pharmaceutical, Teva, manufacturing

Teva has said it plans to sell a manufacturing facility in Quebec, Canada, to US contract manufacturing organisation Halo Pharmaceutical. …

Lonza profits slide as exchange rates bite

August 9, 2011
Manufacturing and Production CMO, Lonza

A strong Swiss franc has pegged back first-half profits at fine chemical and contract manufacturer Lonza, although the company said …

‘Largest biopharma CMO in Asia’ gets green light

March 25, 2010
Manufacturing and Production Biomanufacturing, CMO, manufacturing

A US biotechnology company is spearheading a project to create what will be the largest biopharmaceutical contract manufacturing organisation in …

Cambrex sales rise in Q3 despite ‘challenging environment’

November 9, 2009
Manufacturing and Production, Research and Development CMO, CRO

Contract development and manufacturing services firm Cambrex saw its sales advance 2% to $58 million in the third quarter on …

DSM looking for new Chinese ingredient partners

November 4, 2009
Manufacturing and Production CMO, DSM

Dutch fine chemicals company DSM has said it will look for new partners in China after dissolving a joint venture …

Lonza cuts staff, issues profits warning

November 2, 2009
Manufacturing and Production CMO

Swiss contract manufacturer and fine chemical firm Lonza has announced it will cut around 5% of its workforce and may …

Chinese contract manufacturers to benefit from downturn

February 2, 2009
Manufacturing and Production CMO, China

China's contract manufacturing organisation market was valued at more than $70 billion in 2007, with pharmaceuticals comfortably the largest contributor, …

The Gateway to Local Adoption Series

Latest content